Irfan Budhani, MD
Pulmonary Disease · Florence, KYNPI 1609079540
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.8%), education and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 65.1% of it on its own, with 37 other manufacturers making up the rest. Among pulmonary disease clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $51.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- GSK$2K
- AstraZeneca$1K
- Galvanize Therapeutics, Inc$463
- Boehringer Ingelheim$304
- Mallinckrodt Hospital Products Inc.$297
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$2,50013%
- Travel & lodging$1,6538%
- Food & beverage$8,83245%
- Education$6,71834%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 32 | $12,837 |
| GSK | 153 | $1,966 |
| AstraZeneca | 34 | $1,080 |
| Galvanize Therapeutics, Inc | 6 | $463 |
| Boehringer Ingelheim | 18 | $304 |
| Mallinckrodt Hospital Products Inc. | 8 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $212 |
| Siemens Medical Solutions USA, Inc. | 1 | $191 |
| Sanofi | 9 | $180 |
| Mylan Specialty L.p. | 10 | $160 |
| Grifols USA, LLC | 9 | $156 |
| Actelion Pharmaceuticals US, Inc. | 10 | $153 |
| Sunovion Pharmaceuticals Inc. | 11 | $134 |
| Merck | 8 | $128 |
| Covidien LP | 1 | $124 |
| Fisher & Paykel Healthcare Inc | 1 | $121 |
| Verona Pharma, Inc. | 6 | $121 |
| Pulmonx Corporation | 6 | $121 |
| Regeneron Healthcare Solutions, Inc. | 6 | $112 |
| Olympus America Inc. | 2 | $110 |
| United Therapeutics Corporation | 5 | $107 |
| Insmed, Inc. | 5 | $88 |
| Body Vision Medical Inc. | 1 | $85 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| Philips North America LLC | 3 | $50 |
| Gilead | 4 | $49 |
| Abiomed | 1 | $46 |
| Electromed, Inc. | 3 | $44 |
| Genentech USA, Inc. | 3 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $36 |
| Advanced Respiratory, Inc | 2 | $29 |
| Mallinckrodt Enterprises LLC | 2 | $29 |
| Vifor Pharma, Inc. | 1 | $21 |
| Amgen | 1 | $18 |
| Novartis | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Circassia Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,255
- ION$6,000
- FISHER & PAYKEL HEALTHCARE$607
- ALIYA SYSTEM$395
- BREZTRI$248
- FASENRA$248
- AIRSUPRA$248
- Cios Spin$191
- LungGPS$124
- IMFINZI$121
- AREXVY$115
How this compares
$19,726 in reported general payments places this provider in the 90th percentile of 226 pulmonary disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 298 | $262,383 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 280 | $233,068 |
| Dupixent PenDupilumab | 25 | $125,400 |
| Dupixent SyringeDupilumab | 13 | $49,442 |
| Breo ElliptaFluticasone/Vilanterol | 83 | $42,378 |
| SymbicortBudesonide/Formoterol Fumarate | 66 | $24,477 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 40 | $23,688 |
| Spiriva RespimatTiotropium Bromide | 39 | $19,878 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $12,842 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $12,748 |
| Spiriva HandihalerTiotropium Bromide | 14 | $9,028 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $8,754 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 77 | $8,654 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 33 | $7,260 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 223 | $6,466 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,966 | $296,947403 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,080 | $292,836379 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat | $304 | $56,40794 claims |
| MerckDulera | $128 | $4,17113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 226 pulmonary disease providers in Kentucky.
Other pulmonary disease in Florence
- John McConnellLouisville$864K
- Erica GregonisRichmond$390K
- Firas KouraGeorgetown$350K
- Harold HallerLouisville$340K
- Steven KoenigMorehead$242K
- Samantha BaahLouisville$226K
- Sandra SchuldheiszSomerset$225K
- Karim El-KershLouisville$180K
- Dennis DohertyLexington$103K
- Josephine MeiLouisville$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.